You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ):提前終止“天津天士力醫藥營銷集團股份有限公司2018年度第一期資產支持票據信託”
格隆匯 11-27 19:54

格隆匯 11 月 27日丨重藥控股(000950.SZ)公佈,公司下屬子公司重慶醫藥集團(天津)醫藥商業有限公司(原“天津天士力醫藥營銷集團股份有限公司”,“重藥天津”)於2018年1月17日發行了2018年第一期應收賬款資產支持票據。

重藥天津於2020年8月成為公司合併報表範圍內子公司,現根據實際情況,決定提前終止“天津天士力醫藥營銷集團股份有限公司2018年度第一期資產支持票據信託”。重藥天津於2020年11月26日召開天津天士力醫藥營銷集團股份有限公司2018年度第一期資產支持票據第一次資產支持票據持有人會議,審議通過《關於提前終止“天津天士力醫藥營銷集團股份有限公司2018年度第一期資產支持票據信託”的議案》、《關於審議信託終止後非現金信託財產的《清算方案》的議案》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account